MTSR - NASDAQ

Metsera, Inc.

MTSR·NASDAQ

$70.50

+0.0000%

HealthcareBiotechnology

Metsera, Inc., a clinical-stage biotechnology company, develops injectable and oral nutrient stimulated hormone analog peptides to treat obesity, overweight, and related diseases. It develops MET-097i and MET-233i for the treatment of obesity and overweight; MET-233i/MET-097i; and MET-002, MET-224o, MET-067i, and MET-034i to treat disorders, such as diabetes and obesity. The company was incorporated in 2022 and is headquartered in New York, New York.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$7.43B

EPS-2.0300

P/E Ratio-34.73

Earnings Date03/25/2026

mtsr

Other Non-Current Liabilities

Last Annual Value

87.85M

3-Year CAGR

39%

5-Year CAGR

22%

10-Year CAGR

10%

Adjust for Inflation

Metsera, Inc. Competitors Analysis of Other Non-Current Liabilities

MTSR · NASDAQ

Company	Other Non-Current Liabilities	CAGR 3Y	CAGR 5Y	CAGR 10Y
Metsera, Inc. NASDAQ:MTSR	87.85M	39.3%	N/A	N/A
Arrowhead Pharmaceuticals, Inc. NASDAQ:ARWR	367.40M	N/A	N/A	64.9%
Arcellx, Inc. NASDAQ:ACLX	-44.34M	N/A	N/A	N/A
Axsome Therapeutics, Inc. NASDAQ:AXSM	54.36M	-9.5%	N/A	N/A
Cytokinetics, Incorporated NASDAQ:CYTK	657.76M	20.1%	29.1%	132.6%
Nuvalent, Inc. NASDAQ:NUVL	73.19M	N/A	N/A	N/A
Rhythm Pharmaceuticals, Inc. NASDAQ:RYTM	-3.34M	N/A	N/A	N/A
Vaxcyte, Inc. NASDAQ:PCVX	-111.26M	N/A	N/A	N/A

Metsera, Inc. Fair Value Envelope

MTSR · NASDAQ

Our analysis suggests that MTSR has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $70.5, this represents a potential HIDDEN relative to our calculated worth for Metsera, Inc..

HIDDEN

Intrinsic Value

Current Price: $70.5

Related Guides

Blog Categories

Continue your MTSR research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.